Vertigo News and Research

Latest Vertigo News and Research

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures.

12 Aug 2010

Special issue on new developments in vestibular rehabilitation

Rehabilitation is essential for patients with disabling symptoms of dizziness, vertigo, and unsteadiness caused by disorders of the vestibular system. A special issue of The Journal of Neurologic Physical Therapy (JNPT) presents an update on new and emerging vestibular rehabilitation techniques, highlighting the physical therapist's role on the multidisciplinary teams providing patient care and research.

4 Aug 2010

No increased risk of childhood cancer if born near mobile phone stations: Study

There have been concerns regarding increased risk for cancer in children born to mothers who lived near mobile phone stations during their pregnancy after a report of a cluster of childhood cancer cases near such stations. A newly published study in the British Medical Journal refutes such beliefs and has found no link to early childhood cancers and living near mobile phone masts.

22 Jun 2010

Parents are little aware of concussion risks and support school policies to minimize them: Poll

With growing media attention to concussions among athletes young and old, and recent actions of the National Football League to reduce dangers from multiple concussions among its players, the spotlight is now on what schools are doing to protect their student-athletes. Do parents feel that their kids are safe, and do parents agree with school policies?

14 Jun 2010

Designation of operating rooms as "wet" locations could prevent electrical injury to patients, OR personnel

A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 May 2010

AANS/CNS issue statement on Congress hearing of impact of concussions on high school athletes

On Thursday, May 20, 2010, the U.S. House of Representatives Committee on Education and Labor held a hearing to learn more about the impact of concussions on high school athletes and how the injury can impact academic achievement. A concussion is an injury to the brain that results in loss of normal brain function and is usually temporary.

20 May 2010

ASPO meeting to focus on children's ear, nose and throat health

The American Society of Pediatric Otolaryngology will hold its annual meeting, April 30 - May 2, during the 2010 Combined Otolaryngology Spring Meetings - a joint meeting of eight otolaryngological societies in Las Vegas, NV.

27 Apr 2010

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure Ltd., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., has received notice of allowance from the US Patent Office for its two key patent applications covering methods of use and compositions covering the use of betahistine with olanzapine for the mitigation of the serious weight gain associated as a side effect of the antipsychotic drug.

23 Feb 2010

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.

17 Feb 2010

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

17 Feb 2010

Research findings may open door to new therapeutic strategies for serious health problems

Drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions including heart attack and stroke. Using a new way to screen for potential drugs, a team led by Massachusetts General Hospital (MGH) researchers has identified several FDA-approved agents, including an over-the-counter anti-nausea drug, that can shift cellular energy metabolism processes in animals.

15 Feb 2010

Complications associated with pediatric cochlear implants are not rare and can often be delayed

Some complications may occur in children receiving cochlear implants, and are highly correlated with trauma to the ear area and inner ear malformation, according to a report in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

19 Jan 2010

Hot Ideas World creates Eye-POD Eye Care Kit

The Eye-POD Eye Care Kit has just been created by an entrepreneurial R&D company in Florida, Hot Ideas World, Inc. The array of easy to use functions in the device changes the way users wear Contact Lenses and use Eye Drops.

11 Dec 2009

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Geisinger Medical Center recently opened a new Otolaryngology Head and Neck Surgery - Vestibular and Balance Center to help patients who are affected by vertigo, dizziness or balance problems.

4 Dec 2009

New approach to identify molecules that prevent immune cells from attacking body

A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add a powerful new tool to the ongoing search for potential treatments for autoimmune diseases, such as multiple sclerosis (MS), as well as blood cancers, such as myeloid leukemia.

2 Dec 2009

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.

26 Oct 2009

Physical therapists stress on definitive vestibular screenings and assessment measures for BITBI

Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.

19 Oct 2009

Vertigo News and Research

Latest Vertigo News and Research

FDA advisory committee votes in favor of investigational anti-epileptic drug ezogabine

Special issue on new developments in vestibular rehabilitation

No increased risk of childhood cancer if born near mobile phone stations: Study

Parents are little aware of concussion risks and support school policies to minimize them: Poll

Designation of operating rooms as "wet" locations could prevent electrical injury to patients, OR personnel

AANS/CNS issue statement on Congress hearing of impact of concussions on high school athletes

ASPO meeting to focus on children's ear, nose and throat health

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Research findings may open door to new therapeutic strategies for serious health problems

Complications associated with pediatric cochlear implants are not rare and can often be delayed

Hot Ideas World creates Eye-POD Eye Care Kit

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

New approach to identify molecules that prevent immune cells from attacking body

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Physical therapists stress on definitive vestibular screenings and assessment measures for BITBI

Inner ear balance disorders common, linked to falls among American seniors

Osteoporosis linked to vertigo

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Vertigo News and Research

Latest Vertigo News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in